Proteome Sciences plc (LON:PRM – Get Free Report)’s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 3.38 ($0.04) and traded as low as GBX 2.57 ($0.03). Proteome Sciences shares last traded at GBX 2.76 ($0.04), with a volume of 10,000 shares traded.
Proteome Sciences Price Performance
The stock has a market capitalization of £8.15 million, a PE ratio of -276.00 and a beta of 0.07. The stock’s 50 day moving average is GBX 3.04 and its two-hundred day moving average is GBX 3.38.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
See Also
- Five stocks we like better than Proteome Sciences
- What Makes a Stock a Good Dividend Stock?
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- NYSE Stocks Give Investors a Variety of Quality Options
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
